Literature DB >> 11940206

Alpha-fetoprotein-producing lung carcinoma: report of three cases.

Kenzo Hiroshima1, Akira Iyoda, Tetsuya Toyozaki, Yukiko Haga, Masayuki Baba, Takehiko Fujisawa, Hiroshi Ishikura, Hidemi Ohwada.   

Abstract

Three cases of alpha-fetoprotein (AFP)-producing lung carcinoma were studied histologically and immunohistochemically. Samples were obtained from two men and one woman who ranged in age from 64 to 71 years. Serum AFP levels for the three samples were 9826, 74.4 and 24.3 ng/mL. One case was classified as stage IIIA and two as stage IIIB. Two cases were diagnosed as large cell neuroendocrine carcinoma, and AFP expression was detected immunohistochemically. One of these samples showed differentiation to a hepatoid carcinoma, while the other was combined with a squamous cell carcinoma. The remaining case was a squamous cell carcinoma, and AFP was detected in only some of the tumor cells. All patients died within 2 years. The Ki-67 labeling indices of the AFP-producing pulmonary carcinomas (30.2 +/- 4.6%) were significantly higher than those of AFP-negative pulmonary carcinomas (P < 0.05). The high proliferative activity, advanced stage at presentation, vascular endothelial growth factor expression and vascular invasion observed in these tumors may explain the poor prognosis of AFP-producing lung carcinomas.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11940206     DOI: 10.1046/j.1440-1827.2002.01311.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  24 in total

1.  Surveillance and diagnosis of hepatocellular carcinoma in patients with cirrhosis.

Authors:  Lorenzo Andreana; Graziella Isgrò; Maria Pleguezuelo; Giacomo Germani; Andrew K Burroughs
Journal:  World J Hepatol       Date:  2009-10-31

2.  Establishment and characterization of HEPFT, a cell line derived from hepatoid carcinoma of the fallopian tube, with special reference to alpha-fetoprotein, lectin affinity and histogenesis.

Authors:  Iwao Ishiwata; Makoto Yasuda; Takashi Hirano; Hiroshi Ishikawa
Journal:  Hum Cell       Date:  2007-11       Impact factor: 4.174

3.  Mediastinal hepatocellular carcinoma with unknown primary: an unusual and rare presentation.

Authors:  Peng Soon Koh; Mastura Md Yusof; Boon Koon Yoong; Pathmanathan Rajadurai
Journal:  J Gastrointest Cancer       Date:  2014-12

Review 4.  Hepatoid adenocarcinoma of the lung: a case report and review of the literature.

Authors:  Walid Shaib; Rahul Sharma; Marina Mosunjac; Alton B Farris; Bassel El Rayes
Journal:  J Gastrointest Cancer       Date:  2014-12

Review 5.  Merged hepatopulmonary features in hepatoid adenocarcinoma of the lung: a systematic review.

Authors:  Jia-Xi Mao; Cong Liu; Yuan-Yu Zhao; Guo-Shan Ding; Ji-Qing Ma; Fei Teng; Wen-Yuan Guo
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

6.  A unique case of an alpha-fetoprotein-producing lung cancer with testicular metastasis.

Authors:  Jennifer M Willder; Andrew M Thomson; Kenneth M Grigor; Grahame Howard; Grant D Stewart
Journal:  Can Urol Assoc J       Date:  2012-10       Impact factor: 1.862

7.  Fetal onset of aberrant gene expression relevant to pulmonary carcinogenesis in lung adenocarcinoma development induced by in utero arsenic exposure.

Authors:  Jun Shen; Jie Liu; Yaxiong Xie; Bhalchandra A Diwan; Michael P Waalkes
Journal:  Toxicol Sci       Date:  2006-10-31       Impact factor: 4.849

Review 8.  Diagnosis of hepatocellular carcinoma.

Authors:  Asmaa I Gomaa; Shahid A Khan; Edward L S Leen; Imam Waked; Simon D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

9.  Hepatoid adenocarcinoma of the lung without production of α-fetoprotein: A case report and review of the literature.

Authors:  Ji Ning Sun; Bao Long Zhang; Lin Kun Li; Hai Yan Yu; Bin Wang
Journal:  Oncol Lett       Date:  2016-05-13       Impact factor: 2.967

10.  Soft-Tissue Localization of Hepatoid Adenocarcinoma: First Case Report.

Authors:  Francesca Fornasa
Journal:  Case Rep Oncol       Date:  2010-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.